Nao Medical offers Vivitrol evaluation, monthly injection scheduling, benefits review, and follow-up across NYC and Long Island for both alcohol-dependence treatment and relapse prevention after opioid detoxification.
Vivitrol coverage can depend on the office visit, medication benefit, prior authorization, and how the injection is supplied. The team can verify benefits before the schedule is finalized.
Self-pay can also be reviewed when insurance is not usable or when a patient wants a clearer upfront path. The visit, medication, and administration components are not always one bundled number, so the team walks through the financial path before the first injection is locked.
Nao Medical offers Vivitrol evaluation, monthly injection scheduling, benefits review, and follow-up across NYC and Long Island for both alcohol-dependence treatment and relapse prevention after opioid detoxification.
Patients should already be able to abstain from alcohol in an outpatient setting and should not be actively drinking when the initial injection is given.
The FDA label recommends at least 7 to 10 opioid-free days before starting treatment for opioid use disorder. The clinician may recommend a longer interval based on the opioid involved and the risk of precipitated withdrawal.
Vivitrol is a once-monthly injection. That makes schedule reliability, local access, and realistic follow-up part of the treatment plan.
The team reviews insurance, prior authorization, medication supply workflow, and whether a self-pay path needs to be discussed before the first injection is booked.
Choose a nearby clinic for the first evaluation. The team will confirm medication approval, delivery, and the administration site before scheduling an injection.
Bronx
932 E 174th St, Bronx, NY 10460
A Bronx location for monthly Vivitrol treatment planning, benefits review, and follow-up for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods who need care for alcohol dependence or opioid relapse prevention.
View local Vivitrol care Get directions
Queens
37-15 23rd Ave, Astoria, NY 11105
A Queens location for monthly Vivitrol treatment planning, benefits review, and follow-up for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods who need care for alcohol dependence or opioid relapse prevention.
View local Vivitrol care Get directions
Bronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx location for monthly Vivitrol treatment planning, benefits review, and follow-up for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods who need care for alcohol dependence or opioid relapse prevention.
View local Vivitrol care Get directions
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
A Brooklyn location for monthly Vivitrol treatment planning, benefits review, and follow-up for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods who need care for alcohol dependence or opioid relapse prevention.
View local Vivitrol care Get directions
Long Island
232 W Old Country Rd, Hicksville, NY 11801
A Long Island location for monthly Vivitrol treatment planning, benefits review, and follow-up for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities who need care for alcohol dependence or opioid relapse prevention.
View local Vivitrol care Get directions
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
A Queens location for monthly Vivitrol treatment planning, benefits review, and follow-up for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods who need care for alcohol dependence or opioid relapse prevention.
View local Vivitrol care Get directions
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
A Queens location for monthly Vivitrol treatment planning, benefits review, and follow-up for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods who need care for alcohol dependence or opioid relapse prevention.
View local Vivitrol care Get directions
Queens
30-07 36th Ave, Astoria, NY 11106
A Queens location for monthly Vivitrol treatment planning, benefits review, and follow-up for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods who need care for alcohol dependence or opioid relapse prevention.
View local Vivitrol care Get directions
Long Island
135 Mineola Blvd, Mineola, NY 11501
A Long Island location for monthly Vivitrol treatment planning, benefits review, and follow-up for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities who need care for alcohol dependence or opioid relapse prevention.
View local Vivitrol care Get directions
Manhattan
259 1st Ave, New York, NY 10003
A Manhattan location for monthly Vivitrol treatment planning, benefits review, and follow-up for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods who need care for alcohol dependence or opioid relapse prevention.
View local Vivitrol care Get directions
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
A Brooklyn location for monthly Vivitrol treatment planning, benefits review, and follow-up for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods who need care for alcohol dependence or opioid relapse prevention.
View local Vivitrol care Get directionsFor alcohol dependence, Vivitrol is used in patients who are able to abstain from alcohol in an outpatient setting before starting treatment. Patients should not be actively drinking at the time of the initial injection.
For opioid use disorder, Vivitrol is used to help prevent relapse after opioid detoxification. For opioid use disorder, the FDA label recommends an opioid-free period of at least 7 to 10 days before starting Vivitrol. A longer interval may be needed after some long-acting opioids, including a transition from buprenorphine or another long-acting opioid treatment, so the clinician reviews timing and withdrawal risk individually.
Before the first Vivitrol visit, patients should be ready to review recent opioid or alcohol use, detox or rehab history, prior naltrexone exposure, all current medications, pregnancy or breastfeeding questions, liver-disease history, and whether opioid pain medication may still be needed in the near future.
The first step is deciding whether alcohol-dependence treatment or opioid relapse prevention is the real reason for the visit, then confirming that Vivitrol is clinically appropriate.
Because Vivitrol is monthly, the program has to work beyond one appointment. The clinic, the calendar, and the follow-up plan all matter.
The visit, medication, prior authorization, and supply path are reviewed before the first injection is locked so the patient is not surprised after the intake.
Vivitrol works best inside a broader recovery plan, not as a stand-alone injection with no counseling, psychiatry, or primary-care coordination.
Patients looking for alcohol relapse-prevention medication can review Disulfiram, also called Antabuse, as part of a supervised alcohol-use-disorder medication plan.
The umbrella MAT overview covers the full opioid-treatment picture, including same-day access, bridge visits, fentanyl-related planning, and nearby evaluation locations.
The Suboxone overview covers ongoing buprenorphine treatment rather than monthly naltrexone injection care.
The Sublocade overview covers monthly buprenorphine injection care when that is the relevant comparison to monthly Vivitrol treatment.
Medication comparison separates Suboxone, Sublocade, Vivitrol, and naloxone safety planning so patients can understand which question each one answers.
Naloxone is overdose reversal support and belongs in the safety conversation around opioid relapse risk.
Scheduling guidance covers first-injection timing, missed-dose planning, and choosing a clinic that works for monthly follow-up.
Benefits guidance covers insurance, prior authorization, medication coverage, and whether a self-pay path makes sense.
Pre-visit guidance covers alcohol abstinence, opioid-free timing, medication history, and safety questions that affect whether Vivitrol is the right next step.
Patients can move from the opioid MAT pathway into alcohol care, counseling, documentation review, post-rehab follow-up, or Medicaid coverage review without starting over.
Private addiction medicine, counseling coordination, insurance review, and local follow-up across NYC and Long Island.
Medical review, counseling coordination, relapse-prevention planning, and Vivitrol or naltrexone discussion when appropriate.
Private assessment, counseling coordination, mental-health review, and specialized referral guidance when needed.
Documentation, testing, MAT, counseling, and probation or court paperwork can be reviewed when instructions are brought in writing.
Outpatient follow-up can help maintain medication, counseling, insurance, and relapse-prevention planning after discharge.
Individual counseling, group therapy planning, certified substance-use counseling support, and MAT coordination.
Compare medication, visit, and follow-up options, then choose the care path that fits your current needs.
Buprenorphine-naloxone evaluation, medication planning, and ongoing follow-up.
Evaluation of oral and long-acting buprenorphine options for opioid use disorder.
Monthly extended-release buprenorphine evaluation, access coordination, and in-clinic administration planning.
Weekly or monthly extended-release buprenorphine evaluation, coverage coordination, and treatment planning.
Fast assessment without promising that medication can or should start before timing and safety are reviewed.
Assessment of withdrawal, product type, 7-OH exposure, opioid overlap, and appropriate next steps.
These public clinical and regulatory sources were checked on August 1, 2026. They support the general information and do not replace an individual medical evaluation.
Current indications, opioid-free timing, monthly dosing, overdose vulnerability, injection requirements, and safety information.
New York guidance on extended-release naltrexone and other evidence-based medication options.
Federal treatment information for opioid and alcohol use disorders.
Use location details for address, directions, local scheduling context, and the next step inside the addiction-medicine program.
See Vivitrol evaluation locationsNao Medical operates a New York State OASAS-certified outpatient addiction treatment program. The first visit can focus on the immediate clinical question and medication planning when relevant, or the care plan can include counseling, recovery support, and closer follow-up when that is wanted or clinically recommended.
Patients can request a private evaluation centered on the immediate concern, prescribing or injection planning when applicable, monitoring, and practical next steps. Medication is never automatic; eligibility and safety still require clinician review.
Patients who want more support can add counseling, relapse-prevention work, care coordination, and recovery follow-up through the outpatient addiction program.
After scheduling, complete the confidential addiction intake form when it is sent. It helps the team review current substance use, prior treatment, medications, insurance, and the safest visit type.
Nao Medical accepts Medicaid and many major insurance plans, including Medicare, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare and UnitedHealthcare Community Plan, EmblemHealth, Aetna, Cigna, and Blue Cross Blue Shield. Coverage varies by visit, medication, pharmacy benefit, testing, counseling, and prior authorization. Review addiction-treatment insurance support.
Vivitrol is extended-release injectable naltrexone. Its FDA-approved uses include alcohol dependence in patients who can abstain before treatment and relapse prevention after opioid detoxification. The alcohol pathway can be medication-focused or combined with counseling and recovery support.
Vivitrol is administered every four weeks or once monthly by a healthcare provider after eligibility and safety review.
The visit reviews current drinking, withdrawal risk, liver history, opioid exposure, other medicines, treatment goals, and whether outpatient care is appropriate.
Counseling, relapse-prevention planning, and follow-up are available through Nao Medical's OASAS-certified outpatient program.
Compare alcohol-use-disorder medications, Vivitrol treatment, oral naltrexone, acamprosate, and disulfiram. Medication does not replace emergency care for dangerous alcohol withdrawal.
General information only. The information here is not medical advice and does not replace diagnosis, treatment, or guidance from a licensed clinician.
Content was updated August 2, 2026 from the cited sources and Nao Medical's current service information. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.
(917) 310-3371
